| Trial ID: | L4556 |
| Source ID: | NCT01046318
|
| Associated Drug: |
Opc-262
|
| Title: |
A Study of OPC-262 in Patients With Type 2 Diabetes
|
| Acronym: |
|
| Status: |
COMPLETED
|
| Study Results: |
NO
|
| Results: |
|
| Conditions: |
Type 2 Diabetes
|
| Interventions: |
DRUG: OPC-262
|
| Outcome Measures: |
Primary: Changes in HbA1C from baseline to each visit (OC) and Week 52 (LOCF), each visit (OC) and Week 52 (LOCF)|Clinical laboratory tests, every 4 weeks | Secondary: Changes in fasting blood glucose (FBG) from baseline to each visit (OC) and Week 52 (LOCF), each visit (OC) and Week 52 (LOCF)
|
| Sponsor/Collaborators: |
Sponsor: Kyowa Kirin Co., Ltd.
|
| Gender: |
ALL
|
| Age: |
ADULT, OLDER_ADULT
|
| Phases: |
PHASE3
|
| Enrollment: |
100
|
| Study Type: |
INTERVENTIONAL
|
| Study Designs: |
Allocation: NON_RANDOMIZED|Intervention Model: SINGLE_GROUP|Masking: NONE|Primary Purpose: TREATMENT
|
| Start Date: |
2009-11
|
| Completion Date: |
2011-07
|
| Results First Posted: |
|
| Last Update Posted: |
2014-01-08
|
| Locations: |
Chubu Region, Japan|Kanto Region, Japan|Tohoku Region, Japan
|
| URL: |
https://clinicaltrials.gov/show/NCT01046318
|
